Anatara Lifesciences Limited (ASX:ANR) Directors Insider Transactions
The Directors and Chief Executives of Anatara Lifesciences Limited (ASX:ANR) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Anatara Lifesciences Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Anatara Lifesciences Limited to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Anatara Lifesciences Limited Directors/Insider Transactions Activity
List of Insider trades activity from Anatara Lifesciences Limited (ANR).
|08 Sep 2021||MacLeman (Sue)||Non Executive Chairman||32,259||3,774||Purchase at price 0.12 per share.|
|26 Nov 2020||Ramsdale (Tracie Elizabeth)||Former||4,000||-||-|
|18 Nov 2020||Brookes (David Lionel)||Director (Non-Executive)||200,000||21,900||Other at price 0.11 per share.|
|18 Nov 2020||MacLeman (Sue)||Non Executive Chairman||33,333||3,649||Other at price 0.11 per share.|
|18 Nov 2020||Ryan (Jane)||Director (Non-Executive)||133,333||14,599||Other at price 0.11 per share.|
|30 Jun 2020||Lydeamore (Steven)||Chief Executive Officer||149,457||-||-|
|30 Jun 2020||West (Michael)||Chief Operating Officer||82,599||-||-|
|22 Nov 2019||Ramsdale (Tracie Elizabeth)||Director (Non-Executive)||106,810||-||-|
|01 Nov 2019||Brookes (David Lionel)||Director (Non-Executive)||50,000||6,740||Purchase at price 0.13 per share.|
|01 Nov 2019||Ryan (Jane)||Director||49,745||6,531||Other at price 0.13 per share.|